Cisplatin also induces peripheral leukopenia inhibiting all leukocyte subpopulations including neutrophils, monocytes, and lymphocytes, and it was more detrimental on T (CD3+) than B (CD19+) lymphocytes in cancer mice. This evidence concerns the gene CD19 and cancer.